Legal Opinion

In Re Fosamax (Alendronate Sodium) Products Liability Litigation

United States Judicial Panel on Multidistrict Litigation

Decided May 23, 2011No. MDL No. 2243PublishedCited by 1 opinion

1Opinion of the Court

TRANSFER ORDER

JOHN G. HEYBURN II, Chairman.

Before the Panel: * Pursuant to 28 U.S.C. § 1407, defendant Merck Sharp & Dohme Corp. f/k/a Merck & Co., Inc. (Merck) moves for centralization of the 36 actions, pending in eight districts, listed on Schedule A in the District of New Jersey or, in the alternative, the Western District of Louisiana. 1

Plaintiff in the Eastern District of Louisiana potential tag-along action supports centralization in the Western District of Louisiana. Plaintiffs in the Southern District of New York and Eastern District of New York potential tag-along actions support…

2Cases cited2 opinions

  1. In Re Prudential Ins. Co. of America Sales Pract.United States Judicial Panel on Multidistrict Litigation · 2001
  2. In Re Denture Cream Products Liability LitigationUnited States Judicial Panel on Multidistrict Litigation · 2009

3Cited by1 opinion

  1. In Re Fosamax (Alendronate Sodium) Products Liability LitigationCourt of Appeals for the Third Circuit · 2017

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API